[Russian experts' clinical guidelines for acute myeloid leukemia treatment in patients less than 60 years of age]

V G Savchenko; E N Parovichnikova; B V Afanas'ev; S V Gritsaev; S V Semochkin; S N Bondarenko; V V Troitskaia; A N Sokolov; L A Kuz'mina; G A Kliasova; O Iu Baranova; V A Lapin; T S Konstantinova; O S Samoĭlova; T S Kaporskaia; S V Shatokhin

[Russian experts' clinical guidelines for acute myeloid leukemia treatment in patients less than 60 years of age]

Ter Arkh. 2014;86(7):4-13.

[Article in Russian]

Authors

V G Savchenko, E N Parovichnikova, B V Afanas'ev, S V Gritsaev, S V Semochkin, S N Bondarenko, V V Troitskaia, A N Sokolov, L A Kuz'mina, G A Kliasova, O Iu Baranova, V A Lapin, T S Konstantinova, O S Samoĭlova, T S Kaporskaia, S V Shatokhin

PMID: 25314772

Abstract

The purpose of the paper is to present Russian experts' consolidated opinion about acute myeloid leukemia (AML) treatment in adult patients aged less than 60 years. The guidelines have been elaborated having regard to foreign publications and Russian experience, on the basis of global and Russian clinical trials to treat AML and to define indications for allogeneic bone marrow transplantation in patients during first complete remission.

Publication types

Editorial
English Abstract

MeSH terms

Adolescent
Adult
Age Factors
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / adverse effects
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Consolidation Chemotherapy
Hematopoietic Stem Cell Transplantation*
Humans
Leukemia, Myeloid, Acute / complications
Leukemia, Myeloid, Acute / genetics
Leukemia, Myeloid, Acute / mortality
Leukemia, Myeloid, Acute / therapy*
Maintenance Chemotherapy
Middle Aged
Practice Guidelines as Topic*
Remission Induction
Young Adult